Andog, Anna Marie .
HRN: 22-06-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2023
CEFUROXIME 1.5GM (VIAL)
05/17/2023
05/24/2023
IV
1.5 Gm
Q8
Anemia Severe Sec To PostPartum Hemorrhage; G3P3 (3003)
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes